US Patent 8012976 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
Patent 8012976 was granted and assigned to Biomarin Pharmaceutical on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+89 characters)
Article
Patent abstract
A compound having the structure set forth in Formula (I) and Formula (II):
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Bing Wang0
Daniel Chu0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08012976 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) US Patent 8012976 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
Infobox
Patent Number
080129760
Patent Number
80129760
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080129760
Date of Patent
September 6, 2011
0Patent Application Number
125100960
Date Filed
July 27, 2009
0Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08012976 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08012976
Date of patent
September 6, 2011
Patent application number
12510096
Date Filed
July 27, 2009
Patent primary examiner
Find more entities like US Patent 8012976 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.